Ready, Welcome to the Agoracom Cardiogenics board. IMO this board is vastly superior to the RB board; no name calling or taunting here. Posters are free to post their thoughts and opinions but must be prepared to defend the content of their posts. I too invested in Cardiogenics post the reverse merger and am disappointed in management's handling of IR and technology development. Hopefully, the beta site study will be completed and results announced late November early December. If so and the data is positive we investors will be rewarded for our patience. Ante